Trial Profile
Comparative safety and immunogenicity study of conventional subunit, MF59-adjuvanted and intradermal influenza vaccines in healthy elderly volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2015
Price :
$35
*
At a glance
- Drugs Influenza virus vaccines (Primary) ; MF 59 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 15 Oct 2015 New trial record